Healthy control subjects (n=56) | At-risk subjects (n=60) | IS patients (n=72) | |
Age (year) | 66.36±11.19 | 68.64±10.14 | 69.54±13.69 |
Gender (male/female) | 30/26 | 38/22 | 43/29 |
Smoking (n, %) | 6 (10.71) | 7 (11.67) | 8 (11.11) |
Hypertension (n, %) | -- | 37 (62.67) | 49 (68.06) |
Diabetes (n, %) | -- | 11 (18.33) | 15 (20.83) |
Alcohol consumption (n, %) | 3 (5.36) | 2 (6.06) | 4 (5.56) |
SBP | 129.23±18.11 | 150.85±22.70* | 150.39±25.98* |
DBP | 75.09±11.41 | 80.82±11.75 | 85.77±15.02* |
CHOL (mmol/L) | 4.81±0.96 | 4.91±1.41 | 4.75±1.28 |
TG (mmol/L) | 1.05±0.32 | 1.81±1.22* + | 1.30±1.00 |
HDL (mmol/L) | 1.42±0.36 | 1.48±0.50 | 1.54±0.67 |
LDL (mmol/L) | 2.94±1.01 | 3.25±1.67 | 2.74±0.99 |
Hcy (mmol/L) | 9.28±2.55 | 11.83±4.25* | 11.51±4.68* |
SUA (mmol/L) | 299.41±67.82 | 320.68±101.39 | 307.19±118.26 |
Ultrasound parameters | |||
IMT (mm) | 0.85±0.19 | 1.03±0.21* | 1.06±0.20* |
Carotid atherosclerosis (n, %) | 2 (3.57) | 34 (56.67)* | 44 (61.11)* |
Plaque (n, %) | 3 (5.00) | 37 (61.67)* | 42 (58.33)* |
IS subgroups | |||
LAA (n, %) | -- | -- | 30 (41.67) |
CE (n, %) | -- | -- | 23 (31.94) |
SAA (n, %) | -- | -- | 14 (19.44) |
SUE (n, %) | -- | -- | 4 (5.56) |
NIHSS <7 (n, %) | -- | -- | 40 (55.56) |
NIHSS ≥7 (n, %) | -- | -- | 32 (44.44) |
*p<0.05, vs normal control; +p<0.05, vs IS patients.
CE, cardioembolism; CHOL, cholesterol; DBP, diastolic blood pressure; Hcy, homocysteine; HDL, high-density lipoprotein; IMT, intima—media thickness; IS, ischaemic stroke; LAA, large artery atherosclerosis; LDL, low density lipoprotein; SBP, systolic blood pressure; SUA, serum uric acid; SUE, stroke of undetermined cause; TG, triglyceride.